Autonomic emotional syndromes in practice: experiences of therapy with a long-acting drug
Waniek, W.; Pach, J.
Münchener Medizinische Wochenschrift 116(28): 1339-1344
1974
ISSN/ISBN: 0341-3098 PMID: 4212554 Document Number: 76235
Document emailed within 1 workday
Related Documents
Hofmann-Ehrhart, B.; Schulz, U.; Kluge, M.; Wandl-Vergesslich, K.; Waldhauser, F. 1995: Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth Wiener Klinische Wochenschrift 107(14): 413-417Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325
Burns, B.; Grindlay, K.; Dennis, A. 2015: Women's Awareness of, Interest in, and Experiences with Long-acting Reversible and Permanent Contraception Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 25(3): 224-231
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Inagaki, A. 2016: Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option? Seishin Shinkeigaku Zasshi 118(8): 589-597
Pilz, R. 1971: Internal hospital treatment of spinal and joint diseases. Experiences with a new percutaneously acting drug Zeitschrift für Allgemeinmedizin 47(23): 1169-1172
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Das, P.C.; Sarkar, A.K. 1979: A new non-steroidal drug for long-acting contraception Acta Physiologica Polonica 30(3): 389-391
Mandelkar, A.; Anandlakshmi, P.N.; Krishna, U.R.; Ganguli, A.C.; Purandare, V.N. 1978: Long acting systemic steroids in contraceptive practice Journal of Steroid Biochemistry 9(9): 862
Mandelkar, A.; Anandlakshmi, P.N.; Krishna, U.R.; Ganguli, A.C.; Purandare, V.N. 1978: Long acting systemic steroids in contraceptive practice Journal of Steroid Biochemistry 9(9): 862
Lutova, N.B. 2014: The application of long-acting injectable antipsychotics in clinical practice (overcoming of obstacles) Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10): 102-105
Hoffmann, K.O.K. 1995: Experience with long-acting hormonal implants for contraception in a German gynecological private practice Advances in Contraception 11(1): 10
Pace, L.E.; Dolan, B.M.; Tishler, L.W.; Gooding, H.C.; Bartz, D. 2016: Incorporating Long-acting Reversible Contraception into Primary Care: a Training and Practice Innovation Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 26(2): 131-134
Gallo, C.; Vighi, G.; Schroeder, J. 1987: Tenoxicam, a new long-acting non-steroidal anti-inflammatory drug. a placebo-controlled multicenter study La Clinica Terapeutica 120(5): 405-414
Lucke, J.C.; Hall, W.D. 2012: Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception? Addiction 107(6): 1036-1041
Bejerot, S. 1998: Is capsulotomy in obsessive-compulsive syndromes an unnecessary therapeutic method? Good results with drug therapy and behavior therapy Lakartidningen 95(45): 5003-5005
Drtil, M.; Vinar, O.; Taussigová, D. 1973: Maintenance treatment with long-acting neuroleptic drugs in persons with disturbances of social behavior and drug dependence Activitas Nervosa Superior 15(2): 87
Lucke, J.C.; Hall, W.D. 2012: Exploring conditions under which it may be ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception Addiction 107(6): 1049-1050